Evidence map›Paper›PMID 38055451›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2023

Critical assessment of resource waste in staging and follow-up of breast cancer.

Juliana Vieira Biason Bonometto, Claudia Vaz de Melo Sette, Patricia Xavier Santi, Jean Henri Maselli-Schoueri, Auro Del Giglio, Daniel de Iracema Gomes Cubero

Open access · diamondAbstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The Role of AI in Clinical Trial Design and Scientific Writing.Cardiovascular and interventional radiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Juliana Vieira Biason BonomettoCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0009-0002-1541-8859
Claudia Vaz de Melo SetteCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0000-0001-6789-9039
Patricia Xavier SantiCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0009-0005-9432-0615
Jean Henri Maselli-SchoueriCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0000-0003-2509-3592
Auro Del GiglioCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0000-0002-2009-824X
Daniel de Iracema Gomes CuberoCentro Universitário Faculdade de Medicina do ABC, Department of Oncology - Santo André (SP), Brazil.ORCID http://orcid.org/0000-0002-1936-2605
Faculdade de Medicina do ABC · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is a public health problem with both high incidence and cure rates. After treatment, patients are monitored for long periods of time due to the risk of recurrence. Thus, staging and follow-up strategies should consider not only the best results for the patient but also its costs for the public health system.

objectiveThe objective of this study was to quantify the waste of resources on breast cancer follow-up and evaluate its impact on the public health system.

methodsThis is a retrospective analysis of consecutive medical records to identify the intervals between consultations and tests used for staging and during the first 2 years of follow-up of patients with breast cancer treated at a public hospital in Brazil. Data were compared with the guidelines of the main international consensus.

resultsMedical records of 60 consecutive patients treated in 2018 were selected, of whom 52 had 2 or more years of follow-up, and 8 had only 1 year of complete follow-up. A total of 34 patients (56.67%) underwent excessive examinations for stating. During follow-up, 125 surplus consultations were performed (33.6%). In this phase, 111 surplus exams were also performed, representing an increase of 100.9%. A total of 423 laboratory tests were performed for 18 patients in the first year and 229 tests for 14 patients in the second year.

conclusionExcessive tests and consultations significantly burdened the Unified Health System without any benefit to patients. Better adherence to staging and follow-up recommendations could reduce costs and optimize the limited resources used in the public health system.

Indexed as

Breast NeoplasmsBrazilFemaleFollow-Up StudiesHumansNeoplasm StagingPhysical ExaminationRetrospective Studies

Identifiers

PMID38055451
PMCPMC10691367
OpenAlexW4388972417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.